Makes orthopaedic implants and surgical equipment for joint replacement and sports medicine procedures.
Dec 2025Revenue $6.16B/yrExpenses $5.37B/yr
No trend
Figures by year
Is Smith & Nephew profitable?
Yes. In the 12 months to Dec 2025, revenue was $6.16B and expenses $5.37B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $6.16B | $5.37B | $794M |
| Dec 2024 | $5.81B | $5.15B | $657M |
| Dec 2023 | $5.55B | $5.12B | $425M |
| Dec 2022 | $5.21B | $4.76B | $450M |
| Dec 2021 | $5.21B | $4.62B | $593M |
| Dec 2020 | $4.56B | $4.26B | $295M |
| Dec 2019 | $5.14B | $4.32B | $815M |
| Dec 2018 | $4.90B | $4.04B | $863M |
| Dec 2017 | $4.76B | $3.83B | $934M |
| Dec 2016 | $4.67B | $3.87B | $801M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.